Cargando…

Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials

Targeted therapies such as oral tyrosine kinase inhibitors (TKIs) are the main therapeutic strategy effective for advanced hepatocellular carcinoma (HCC). Currently six tyrosine kinase inhibitors for HCC therapy have been approved. The newly approved first-line drug donafenib represent the major mil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mou, Lisha, Tian, Xiaohe, Zhou, Bo, Zhan, Yongqiang, Chen, Jiao, Lu, Ying, Deng, Jing, Deng, Ying, Wu, Zijing, Li, Qi, Song, Yi’an, Zhang, Hongyuan, Chen, Jinjun, Tian, Kuifeng, Ni, Yong, Pu, Zuhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543014/ https://www.ncbi.nlm.nih.gov/pubmed/34707994 http://dx.doi.org/10.3389/fonc.2021.752725

Ejemplares similares

Single-Cell RNA Sequencing Reveals the Role of Phosphorylation-Related Genes in Hepatocellular Carcinoma Stem Cells
por: Yao, Fuwen, et al.
Publicado: (2022)

Corrigendum: Single-cell RNA sequencing reveals the role of phosphorylation-related genes in hepatocellular carcinoma stem cells
por: Yao, Fuwen, et al.
Publicado: (2023)

LncRNAs Target Ferroptosis-Related Genes and Impair Activation of CD4(+) T Cell in Gastric Cancer
por: Yao, Fuwen, et al.
Publicado: (2021)

Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis
por: Li, Zhenjie, et al.
Publicado: (2019)

Two-field non-mydriatic fundus photography for diabetic retinopathy screening: a protocol for a systematic review and meta-analysis
por: Yu, Dongjing, et al.
Publicado: (2021)

Current Topics of Relevance to the Xenotransplantation of Free Pig Islets
por: Mou, Lisha, et al.
Publicado: (2022)

Single-Cell Landscape of Mouse Islet Allograft and Syngeneic Graft
por: Chen, Pengfei, et al.
Publicado: (2022)

Clinical and Prognostic Value of PPIA, SQSTM1, and CCL20 in Hepatocellular Carcinoma Patients by Single-Cell Transcriptome Analysis
por: Mou, Lisha, et al.
Publicado: (2022)

Construction of a novel predictive model with seven metabolism-related genes for hepatocellular carcinoma by machine learning
por: Mou, Lisha, et al.
Publicado: (2023)

Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy
por: Zhan, Yongqiang, et al.
Publicado: (2016)

Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis
por: Mou, Lisha, et al.
Publicado: (2023)

The Immune Atlas of Human Deciduas With Unexplained Recurrent Pregnancy Loss
por: Chen, Pengfei, et al.
Publicado: (2021)

Single-cell RNA analysis to identify five cytokines signaling in immune-related genes for melanoma survival prognosis
por: Pu, Zuhui, et al.
Publicado: (2023)

The transcriptome profile of RPE cells by the fullerenol against hydrogen peroxide stress
por: Wu, Xiaojun, et al.
Publicado: (2022)

MicroRNA-135a expression is upregulated in hepatocellular carcinoma and targets long non-coding RNA TONSL-AS1 to suppress cell proliferation
por: Deng, Xuesong, et al.
Publicado: (2021)

Kindlin-2 promotes Src-mediated tyrosine phosphorylation of androgen receptor and contributes to breast cancer progression
por: Ma, Luyao, et al.
Publicado: (2022)

Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment
por: Chen, Ruyin, et al.
Publicado: (2022)

Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors
por: Schöffski, P, et al.
Publicado: (2010)

Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination
por: Zhou, Yuanfeng, et al.
Publicado: (2018)

Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate‐Stage Hepatocellular Carcinoma, What Else Can We Do?
por: Deng, Jun, et al.
Publicado: (2022)

Reply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors
por: Novello, S, et al.
Publicado: (2010)

Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experience
por: Luo, Laihui, et al.
Publicado: (2022)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2016)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2020)

Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues
por: Zhou, Donghui, et al.
Publicado: (2008)

EGFR Tyrosine Kinase Inhibitor Efficacy in Older Adult Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review
por: Chen, Chang-Hung, et al.
Publicado: (2022)

Selection criteria in liver transplantation for hepatocellular carcinoma: an ongoing evolution
por: Line, Pål-Dag
Publicado: (2022)

Contribution of hepatitis B virus X protein-induced aberrant microRNA expression to hepatocellular carcinoma pathogenesis
por: WEI, Zhiyuan, et al.
Publicado: (2019)

Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases
por: Zhu, Ying, et al.
Publicado: (2021)

EGFR tyrosine kinase inhibitors promote pro-caspase-8 dimerization that sensitizes cancer cells to DNA-damaging therapy
por: Li, Yun-Tian, et al.
Publicado: (2015)

Identification and Characterization of the Amphioxus Lck and Its Associated Tyrosine Phosphorylation-Dependent Inhibitory LRR Receptor
por: Zhou, Jiatao, et al.
Publicado: (2021)

Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma
por: Liang, Linjun, et al.
Publicado: (2023)

Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling
por: Zhao, Qingxia, et al.
Publicado: (2019)

Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2015)

Evolutionary History and Ongoing Transmission of Phylogenetic Sublineages of Mycobacterium tuberculosis Beijing Genotype in China
por: Yin, Qing-qin, et al.
Publicado: (2016)

Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis
por: Deng, Jia, et al.
Publicado: (2023)

MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2
por: Zan, Ying, et al.
Publicado: (2019)

Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review)
por: Chen, Yi-Li, et al.
Publicado: (2023)

Male infertility-related molecules involved in sperm-oocyte fusion
por: MOU, Lisha, et al.
Publicado: (2016)

Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review
por: Liang, Bin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c4ea6jto8cvgfmhkc49t1sn65n